Log In
BCIQ
Print this Print this
 

TCN-P (Triciribine phosphate monohydrate) (PTX-200) (formerly VQD-002)

  Manage Alerts
Collapse Summary General Information
Company Cahaba Pharmaceuticals
DescriptionTricyclic nucleoside inhibitor of protein kinase B (PKB) (PKBA) (AKT) (AKT1) phosphorylation
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA)
Mechanism of ActionProtein kinase B (PKB) (AKT1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.5M

$0.3M

$0.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/11/2014

$1.5M

$0.3M

$0.5M

Get a free BioCentury trial today